308 related articles for article (PubMed ID: 8579622)
1. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women.
Dallongeville J; Marecaux N; Isorez D; Zylbergberg G; Fruchart JC; Amouyel P
Atherosclerosis; 1995 Nov; 118(1):123-33. PubMed ID: 8579622
[TBL] [Abstract][Full Text] [Related]
2. Coronary heart disease risk factors and menopause: a study in 1684 French women.
Trémollières FA; Pouilles JM; Cauneille C; Ribot C
Atherosclerosis; 1999 Feb; 142(2):415-23. PubMed ID: 10030394
[TBL] [Abstract][Full Text] [Related]
3. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment.
Milman N; Kirchhoff M; Jørgensen T
Ann Hematol; 1992 Aug; 65(2):96-102. PubMed ID: 1511065
[TBL] [Abstract][Full Text] [Related]
4. Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy.
Lee AJ; Lowe GD; Smith WC; Tunstall-Pedoe H
Br J Haematol; 1993 Apr; 83(4):616-21. PubMed ID: 8518178
[TBL] [Abstract][Full Text] [Related]
5. Transdermal estrogen replacement therapy and plasma lipids in 693 French women.
Bongard V; Ferrières J; Ruidavets JB; Amouyel P; Arveiler D; Bingham A; Ducimetière P
Maturitas; 1998 Nov; 30(3):265-72. PubMed ID: 9881326
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).
Herrington DM; Fong J; Sempos CT; Black DM; Schrott HG; Rautaharju P; Bachorik PS; Blumenthal R; Khan S; Wenger NK
Am Heart J; 1998 Jul; 136(1):115-24. PubMed ID: 9665228
[TBL] [Abstract][Full Text] [Related]
7. Menopause and risk factors for coronary heart disease.
Matthews KA; Meilahn E; Kuller LH; Kelsey SF; Caggiula AW; Wing RR
N Engl J Med; 1989 Sep; 321(10):641-6. PubMed ID: 2488072
[TBL] [Abstract][Full Text] [Related]
8. Haemostatic variables and menopausal status: influence of hormone replacement therapy.
Scarabin PY; Plu-Bureau G; Bara L; Bonithon-Kopp C; Guize L; Samama MM
Thromb Haemost; 1993 Oct; 70(4):584-7. PubMed ID: 8115983
[TBL] [Abstract][Full Text] [Related]
9. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
[TBL] [Abstract][Full Text] [Related]
10. Prior to use of estrogen replacement therapy, are users healthier than nonusers?
Matthews KA; Kuller LH; Wing RR; Meilahn EN; Plantinga P
Am J Epidemiol; 1996 May; 143(10):971-8. PubMed ID: 8629615
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function and perimenopausal lipid and weight changes: the Thyroid Study in Healthy Women (TSH-W).
Massoudi MS; Meilahn EN; Orchard TJ; Foley TP; Kuller LH; Costantino JP; Buhari AM
J Womens Health; 1997 Oct; 6(5):553-8. PubMed ID: 9356978
[TBL] [Abstract][Full Text] [Related]
12. Menopause and modifiable coronary heart disease risk factors: a population based study.
Agrinier N; Cournot M; Dallongeville J; Arveiler D; Ducimetière P; Ruidavets JB; Ferrières J
Maturitas; 2010 Mar; 65(3):237-43. PubMed ID: 20031345
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
14. Coronary heart disease risk factors and menopause: a study in 1980 Tehranian women, the Tehran Lipid and Glucose Study.
Azizi F; Ainy E
Climacteric; 2003 Dec; 6(4):330-6. PubMed ID: 15006254
[TBL] [Abstract][Full Text] [Related]
15. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
[TBL] [Abstract][Full Text] [Related]
16. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
17. Does body mass index, smoking, lipoprotein levels, surgically induced menopause, hormone replacement therapy, years since menopause, or age affect hemostasis in postmenopausal women?
Pripp U; Eriksson-Berg M; Orth-Gomér K; Schenck-Gustafsson K; Landgren BM
Gend Med; 2005 Jun; 2(2):88-95. PubMed ID: 16115603
[TBL] [Abstract][Full Text] [Related]
18. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
19. Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.
Binder EF; Williams DB; Schechtman KB; Jeffe DB; Kohrt WM
Ann Intern Med; 2001 May; 134(9 Pt 1):754-60. PubMed ID: 11329233
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study.
Kuh D; Langenberg C; Hardy R; Kok H; Cooper R; Butterworth S; Wadsworth ME
BJOG; 2005 Apr; 112(4):476-85. PubMed ID: 15777448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
